These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13401934)

  • 41. [Action of cytotoxic drugs in Hodgkin-Sternberg malignant granuloma; electrophoretic changes in blood].
    CHIARIONI T; FRACASSO I; NARDI E
    G Clin Med; 1957 Feb; 38(2):245-69. PubMed ID: 13448428
    [No Abstract]   [Full Text] [Related]  

  • 42. [Late results in the chemotherapy of lymphogranulomatosis].
    LARIONOV LF; ZIV MA
    Vopr Onkol; 1958; 4(2):161-6. PubMed ID: 13557996
    [No Abstract]   [Full Text] [Related]  

  • 43. [Attempted ACTH therapy of malignant lymphogranulomatosis].
    KOWAR-KASZUBOWA T
    Pol Tyg Lek (Wars); 1957 Apr; 12(15):555-6. PubMed ID: 13452959
    [No Abstract]   [Full Text] [Related]  

  • 44. [Duamine with radiotherapy in lymphogranulomatosis].
    SAVCHENKO ED
    Vestn Rentgenol Radiol; 1956; 31(5):60-7. PubMed ID: 13422965
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation, treatment principles and results in lymphogranulomatosis].
    Musshoff K; Boutis L
    Strahlentherapie Sonderb; 1969; 69():59-74. PubMed ID: 5778910
    [No Abstract]   [Full Text] [Related]  

  • 46. [Electrophoretic patterns of blood proteins in Hodgkin's disease].
    FIORILLO AM; JAMRA M
    Rev Assoc Med Bras; 1954 Jun; 1(2):176-8. PubMed ID: 13237517
    [No Abstract]   [Full Text] [Related]  

  • 47. [The blood protein picture in several cases of pulmonary tuberculosis treated with cycloserine].
    CASATI G; CAZZANIGA G; COLOMBI GC
    G Ital Della Tuberc; 1957; 11(6):367-73. PubMed ID: 13501582
    [No Abstract]   [Full Text] [Related]  

  • 48. [Symptomatic psychosis in nitrogen-mustard treatment of a lymphogranulomatosis].
    BRAUN H; EICKE WJ
    Nervenarzt; 1955 Feb; 26(2):71-3. PubMed ID: 14383897
    [No Abstract]   [Full Text] [Related]  

  • 49. [Preliminary data on application of dopamine lymphogranulomatosis].
    IVANOVA EM
    Vopr Onkol; 1957; 3(5):556-62. PubMed ID: 13507321
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of x-ray and triethylene melamine in a case of lymphogranulomatosis].
    VOSS C
    Dtsch Med J; 1955 Feb; 6(3-4):103-5. PubMed ID: 14365476
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cortisone derivatives in the treatment of cancer and of malignant lymphogranulomatosis].
    FAUVET J; ROUJEAU J
    Rev Prat; 1960 Sep; 10():2405-15. PubMed ID: 13698389
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience in the treatment with sanamycin in bronchial asthma and asthmoid emphysematous bronchitis].
    MEYTHALER F; FISCHER H
    Arztl Wochensch; 1958 Jan; 13(1):20-1. PubMed ID: 13508480
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
    KUDRIASHOVA OI
    Vopr Onkol; 1956; 2(5):549-56. PubMed ID: 13392657
    [No Abstract]   [Full Text] [Related]  

  • 54. [A case of Hodgkin's disease. Unsuccessful therapeutic trial with gamma-globulin injections obtained from 13 former patients without apparent clinical manifestations of lymphogranulomatosis for at least 5 years].
    HUIGNARD C; ENNUYER A
    Presse Med (1893); 1961 Apr; 69():920. PubMed ID: 13716715
    [No Abstract]   [Full Text] [Related]  

  • 55. [Surgical intervention in the complex treatment of lymphogranulomatosis].
    Aĭrapetian MKh
    Khirurgiia (Mosk); 1968 Jan; 44(1):111-3. PubMed ID: 5655173
    [No Abstract]   [Full Text] [Related]  

  • 56. [Care of a patient with lymphogranulomatosis].
    Thausing E
    Osterr Krankenpflegez; 1980; 33(5):133-42. PubMed ID: 6900974
    [No Abstract]   [Full Text] [Related]  

  • 57. L. micdadei PVE successfully treated with levofloxacin/valve replacement: case report and review of the literature.
    Patel MC; Levi MH; Mahadevi P; Nana M; Merav AD; Robbins N
    J Infect; 2005 Dec; 51(5):e265-8. PubMed ID: 15996745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in the electrophoretic spectrum of blood proteins after saturation with bacterial suspensions].
    NAUMANN G; WILDE J
    Z Immun exp ther; 1959 Apr; 117(4):325-40. PubMed ID: 13660115
    [No Abstract]   [Full Text] [Related]  

  • 59. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
    Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
    Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological aspects of cycloserine therapy.
    DE SIMONI G; CATTANEO C
    Lotta Tuberc; 1957 Dec; 27(12):1248-9. PubMed ID: 13540301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.